Evaluation of [68Ga]Ga-PSMA PET/CT images acquired with a reduced scan time duration in prostate cancer patients using the digital biograph vision
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2191-219X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Evaluation of [68Ga]Ga-PSMA PET/CT images acquired with a reduced scan time duration in prostate cancer patients using the digital biograph vision ; volume:11 ; number:1 ; day:28 ; month:2 ; year:2021 ; pages:1-12 ; date:12.2021
EJNMMI Research ; 11, Heft 1 (28.2.2021), 1-12, 12.2021
- Creator
-
Weber, Manuel
Jentzen, Walter
Hofferber, Regina
Herrmann, Ken
Fendler, Wolfgang Peter
Conti, Maurizio
Wetter, Axel
Kersting, David
Rischpler, Christoph
Fragoso Costa, Pedro
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13550-021-00765-y
- URN
-
urn:nbn:de:101:1-2021041512093407671636
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Weber, Manuel
- Jentzen, Walter
- Hofferber, Regina
- Herrmann, Ken
- Fendler, Wolfgang Peter
- Conti, Maurizio
- Wetter, Axel
- Kersting, David
- Rischpler, Christoph
- Fragoso Costa, Pedro
- SpringerLink (Online service)
Other Objects (12)
Ressourceneffizienz durch Produktionsplanung und Lean Production
Neuartiges Antriebskonzept zum Fahren, Lenken und Heben
Treatment-related changes in neuroendocrine tumors as assessed by textural features derived from 68Ga-DOTATOC PET/MRI with simultaneous acquisition of apparent diffusion coefficient
Evaluation of 18F-FDG PET/CT images acquired with a reduced scan time duration in lymphoma patients using the digital biograph vision
PSMA PET total tumor volume predicts outcome of patients with advanced prostate cancer receiving [177Lu]Lu-PSMA-617 radioligand therapy in a bicentric analysis
Action-based quantum Monte Carlo approach to fermion-boson models
Assoziation zwischen molekularpathologischen Alterationen beim papillären Schilddrüsenkarzinom und dem Auftreten einer radiojodrefraktären Erkrankung
Changes in tumor-to-blood ratio as a prognostic marker for progression-free survival and overall survival in neuroendocrine tumor patients undergoing PRRT
Just another “Clever Hans”? Neural networks and FDG PET-CT to predict the outcome of patients with breast cancer
2021: the year [177Lu]Lu-PSMA-617 RLT PSMA is ready for incorporation into clinical guidelines? : Reply to “A perspective on the EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands” by Dr. Germo Gericke
Recurrent prostate cancer: combined role for MRI and PSMA-PET in 68Ga-PSMA-11 PET/MRI
The novel PROMISE framework for PSMA-PET reporting: ready for the clinical routine?
Ressourceneffizienz durch Produktionsplanung und Lean Production
Neuartiges Antriebskonzept zum Fahren, Lenken und Heben
Treatment-related changes in neuroendocrine tumors as assessed by textural features derived from 68Ga-DOTATOC PET/MRI with simultaneous acquisition of apparent diffusion coefficient
Evaluation of 18F-FDG PET/CT images acquired with a reduced scan time duration in lymphoma patients using the digital biograph vision
PSMA PET total tumor volume predicts outcome of patients with advanced prostate cancer receiving [177Lu]Lu-PSMA-617 radioligand therapy in a bicentric analysis
Action-based quantum Monte Carlo approach to fermion-boson models
Assoziation zwischen molekularpathologischen Alterationen beim papillären Schilddrüsenkarzinom und dem Auftreten einer radiojodrefraktären Erkrankung
Changes in tumor-to-blood ratio as a prognostic marker for progression-free survival and overall survival in neuroendocrine tumor patients undergoing PRRT
Just another “Clever Hans”? Neural networks and FDG PET-CT to predict the outcome of patients with breast cancer
2021: the year [177Lu]Lu-PSMA-617 RLT PSMA is ready for incorporation into clinical guidelines? : Reply to “A perspective on the EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands” by Dr. Germo Gericke
Recurrent prostate cancer: combined role for MRI and PSMA-PET in 68Ga-PSMA-11 PET/MRI
The novel PROMISE framework for PSMA-PET reporting: ready for the clinical routine?
Ressourceneffizienz durch Produktionsplanung und Lean Production
Neuartiges Antriebskonzept zum Fahren, Lenken und Heben
Treatment-related changes in neuroendocrine tumors as assessed by textural features derived from 68Ga-DOTATOC PET/MRI with simultaneous acquisition of apparent diffusion coefficient
Evaluation of 18F-FDG PET/CT images acquired with a reduced scan time duration in lymphoma patients using the digital biograph vision
PSMA PET total tumor volume predicts outcome of patients with advanced prostate cancer receiving [177Lu]Lu-PSMA-617 radioligand therapy in a bicentric analysis
Action-based quantum Monte Carlo approach to fermion-boson models
Assoziation zwischen molekularpathologischen Alterationen beim papillären Schilddrüsenkarzinom und dem Auftreten einer radiojodrefraktären Erkrankung
Changes in tumor-to-blood ratio as a prognostic marker for progression-free survival and overall survival in neuroendocrine tumor patients undergoing PRRT
Just another “Clever Hans”? Neural networks and FDG PET-CT to predict the outcome of patients with breast cancer
2021: the year [177Lu]Lu-PSMA-617 RLT PSMA is ready for incorporation into clinical guidelines? : Reply to “A perspective on the EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands” by Dr. Germo Gericke
Recurrent prostate cancer: combined role for MRI and PSMA-PET in 68Ga-PSMA-11 PET/MRI